Retatrutide ZPHC (AQ pen) — 30 mg Premixed Pen

Retatrutide — triple GLP-1 / GIP / glucagon receptor agonist
30 mg pre-filled aqueous pen • 300 clicks × 0.1 mg
No mixing required: sterile water-based solution delivered via precision dial-a-dose pen.
Powerful weight-loss synergy: GLP-1, GIP and glucagon receptor activation enhances satiety, slows gastric emptying, improves insulin sensitivity and increases energy expenditure.
Suggested research titration: 0.5 mg weekly → increase by 0.5 mg every 4 weeks up to 2.5 mg, as tolerated.
Each click = 0.1 mg: transparent window shows remaining volume; full pen supplies 300 clicks.
Storage: ship cold; refrigerate 2 – 8 °C once opened; stable 30 days at 25 °C for travel.
QC: ≥ 99 % purity, endotoxin < 0.03 EU/mg; pen sterilised & tamper-evident., Retatrutide ZPHC (AQ pen) — 30 mg Premixed Pen, 159, USD, ,